Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1567-1568
DOI: 10.1111/apt.70672 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-04-15. Written by Runqi Wang and 2 co-authors. Institution: Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 8 references.
Abstract (original language)
Abstract non disponibile.
Authors and institutions
- Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of General Surgery, Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID profiles: Runqi Wang, Zhe Cui
Cite
APA
Wang, R., Cao, D., & Cui, Z. (2026). Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(11), 1567-1568. https://doi.org/10.1111/apt.70672
Vancouver
Wang R, Cao D, Cui Z. Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(11):1567-1568. doi:10.1111/apt.70672
BibTeX
@article{Wang2026,
author = {Wang, Runqi and Cao, Dongxing and Cui, Zhe},
title = {Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {11},
pages = {1567--1568},
doi = {10.1111/apt.70672}
}
EUVIMED